Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1Lung Neoplasms 1Fatigue 1Depression 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Anxiety Disorders 1Advanced Cancer 1Adenocarcinoma of Lung 1

Interventions

Exercise 6Diet 6Octreotide 3Metformin 3Caloric Restriction 3Diet, Carbohydrate-Restricted 2Cognitive Behavioral Therapy 2sibutramine 1remune 1olanzapine-fluoxetine combination 1irinotecan sucrosofate 1bermekimab 1Weight Reduction Programs 1TOPS 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sampling Studies 1Ritonavir 1Resistance Training 1Quality of Life 1Psychology, Positive 1Palonosetron 1Palliative Care 1Olanzapine 1Nutritionists 1Nutritional Status 1Nutrition Assessment 1Methods 1Melatonin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Weight Loss × Fluoxetine × Clear all
NCT00489593 2015-01-08

Olanzapine in Patients With Advanced Cancer and Weight Loss

M.D. Anderson Cancer Center

Phase 1 Completed
57 enrolled

Cachexia, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡